SEC Form 4/A · accession 0001179110-17-010670
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Eric S Fain
Officer — Senior Vice President
Period of report
Jan 4, 2017
Accepted (ET)
Jul 25, 2017 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1,F2 | Jan 4, 2017 | A | 114,240 | — | A | 116,333 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Due to an administrative error that occurred prior to Abbott's acquisition of St. Jude Medical, Inc., the Form 4 filed on January 6, 2017 underreported the Abbott shares received by the reporting person pursuant to the Agreement and Plan of Merger by and among Abbott, St. Jude Medical, Inc., Vault Merger Sub, Inc., and Vault Merger Sub, LLC, by 413 shares.
- F2On January 4, 2017, Abbott Laboratories ("Abbott") acquired St. Jude Medical, Inc. ("St. Jude Medical") pursuant to the Agreement and Plan of Merger by and among Abbott, St. Jude Medical, Vault Merger Sub, Inc. and Vault Merger Sub, LLC dated as of April 27, 2016 (the "Merger Agreement"). Upon the First Effective Time (as defined in the Merger Agreement), each outstanding St. Jude Medical common share (other than certain shares identified in the Merger Agreement) was converted into the right to receive (a) $46.75 in cash, without interest, and (b) 0.8708 common shares of Abbott.